Our cancer researchers are investigating the molecular basis of the disease including sarcoma, melanoma, mesothelioma, breast, colorectal, prostate and biliary tract cancer.
Using model systems, protein and DNA-based technologies and imaging, they are developing new approaches and therapeutic targets to improve clinical diagnosis and treatment.
A close relationship with the Olivia Newton-John Cancer Research Institute enhances bench-to-bedside outcomes.
To understand the molecular mechanisms of cancer including processes that lead to abnormal cell growth.
To identify new treatment strategies with improved efficacy and fewer side effects.
To develop new technologies for imaging and monitoring cancer progression, and to identify new biomarkers for diagnostic purposes.
Each Wednesday at 11am, from 16 September to 14 October, join the La Trobe Institute for Molecular Science, the Olivia Newton-John Cancer Research Institute and the Comprehensive Cancer PhD Program for a seminar on the Hallmarks of Cancer.
Open to researchers, academics and any interested parties. Attendance is via ZOOM.
For more information on the complimentary seminars click: the Hallmarks of Cancer: the Next Generation Seminar Series.